[On the origin of metachromatic substances following treatment with uranyl acetate].
D000085:Acetates / Q000627:therapeutic use*; D000818:Animals; D002115:Calciphylaxis / Q000188:drug therapy*; D002712:Chlorides / Q000627:therapeutic use; D005260:Female; D007279:Injections, Subcutaneous; D008407:Mast Cells; D008670:Metals / Q000378:metabolism; D051381:Rats; D013194:Staining and Labeling; D013793:Thallium; D013910:Thorium; D014501:Uranium
D000085:Acetates; D002712:Chlorides; D008670:Metals; D014501:Uranium; D013910:Thorium; D013793:Thallium
Uber das Entstehen metachromatischer Substanz nach Behandlung mit Uranylazetat.